Cardiovascular Diseases in the Silesian Region in Poland. (SILICARD)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02743533|
Recruitment Status : Recruiting
First Posted : April 19, 2016
Last Update Posted : April 25, 2017
The Silesian Cardiovascular Database is an observational study of all patients hospitalized due to cardiovascular diseases. The date include information on the clinical characteristics, treatment modalities and prognosis in this population.
The data include information on all the applicable diagnostic and therapeutic procedures, prognosis and hospitalization costs. Likewise, data have been collected specialist care outpatient visits and primary health care patients were hospitalized.
|Condition or disease|
The Silesian Cardiovascular Database is an prospective observational study patients who were hospitalized in the Silesian region in Poland due to cardiovascular diseases from 1st January 2006.
The aim of the study is to collect and analyze all epidemiological data, diagnostic and therapeutic procedures, in-hospital and long-term prognosis, hospitalization costs of these patients. Likewise, data have been collected specialist care outpatient visits and primary health care patients were hospitalized.
For the analysis were included patients hospitalized in the cardiology, cardiac surgery , diabetes, vascular surgery wards and who were hospitalized for cardiac diagnosis in the wards of internal medicine and intensive care.
The Silesian Cardiovascular Database was created based on the agreement between Silesian Centre for Heart Diseases in Zabrze and the Regional Department of National Health Fund in Katowice in order to conduct analyses and prepare scientific elaborations on the group of patients with circulatory system diseases. Data elaboration and preparation for analyses was conducted by the Science Department of Silesian Centre for Heart Diseases and the Department of Biostatistics of Medical University of Silesia.
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||10000000 participants|
|Target Follow-Up Duration:||10 Years|
|Official Title:||Trends in the Incidence, Treatment and Prognosis of Cardiovascular Diseases in the Silesian Region in Poland. SILesIan CARdiovascular Database (SILICARD)|
|Study Start Date :||January 2006|
|Estimated Primary Completion Date :||December 2020|
|Estimated Study Completion Date :||December 2021|
- Number of participants with reported deaths from any cause [ Time Frame: From date of inclusion until the date of death from any cause, assessed up to 1 year ]
- Trends in the number of hospitalization due to cardiovascular diseases [ Time Frame: 1 year ]
- Trends in the number of diagnostic and therapeutic procedures [ Time Frame: 1 year ]
- Number of participants with reported rehospitalization [ Time Frame: From date of inclusion until the date of first event, assessed up to 1 year ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02743533
|Contact: Damian Pres, MDemail@example.com|
|Silesian Center for Heart Diseases||Recruiting|
|Zabrze, Poland, 41-800|
|Contact: Damian Pres, M.D. +48667288320 firstname.lastname@example.org|
|Principal Investigator:||Mariusz Gasior, Prof., PhD||3rd Chair and Department of Cardiology, Silesian Center for Heart Diseases, Zabrze, Poland|
|Study Chair:||Damian Pres, MD||3rd Chair and Department of Cardiology, Silesian Center for Heart Diseases, Zabrze, Poland|